Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Atrix Laboratories, Inc. — Predicate Candidate Screening
3 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K994137 | ATRISORB-D FREEFLOW BIOABSORBABLE GUIDED TISSUE REGENERATION | Atrix Laboratories, Inc. | 2000-09-13 | 281 | 0 |
| K982865 | ATRISORB BIOABSORBABLE GUIDED TISSUE REGENERATION (GTR) BARR | Atrix Laboratories, Inc. | 1998-09-08 | 26 | 1 |
| K955838 | ATRISORB BIOABSORBABLE GUIDED TISSUE REGNERATION(GTR) | Atrix Laboratories, Inc. | 1996-03-21 | 90 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda